

BPC-157
$65.00
Quantity
BPC‑157, known as “Body Protection Compound‑157,” has become a notable focus in laboratory research. First identified in human gastric secretions, this peptide exhibits remarkable protective and reparative effects across multiple tissue types. What sets BPC‑157 apart is its resilience—while many peptides degrade rapidly, BPC‑157 maintains stability even under harsh conditions such as gastric acid, making it a highly valuable candidate for diverse experimental investigations.
Weight: 0.08 lbs
Dimensions: 0.87 × 1.18 × 0.87 in
Size: 10mg, 5mg
This product is intended solely for research purposes. It is not authorized for use in humans or animals and should only be handled by trained personnel in appropriate laboratory settings.
Appearance: White to off‑white lyophilized powder
Solubility: Readily dissolves in water
Stability: Stable across a wide range of pH conditions
Storage Conditions: Refrigerate at 36‑46 °F (2‑8 °C)
Chemical Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1419.54 g/mol
Sequence: Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val
CAS: 137525‑51‑0
BPC‑157 functions via diverse intriguing pathways that scientists continue to investigate:
Vascular Support
Encourages the development of new blood vessels, creating efficient routes for nutrients and repair agents to reach injured tissues.
Growth Signal Enhancement
Amplifies production of mediators such as VEGF and IGF‑1, orchestrating cellular recovery and regeneration.
Nitric Oxide Pathways
Engages with NO signaling to optimize circulation and improve intercellular communication.
Collagen Remodeling
Facilitates organized collagen deposition, strengthening tissue structure and flexibility during repair.
Inflammatory Modulation
Reduces harmful inflammatory signals while promoting restorative pathways.
Cellular Defense
Protects cells against oxidative and environmental stressors.
Tissue Stability
Helps preserve tissue integrity under challenging conditions.
Systemic Integration
Appears to harmonize healing responses across multiple organ systems.
The variety of BPC‑157’s demonstrated properties in research is remarkable:
Originating from gastric proteins, BPC‑157 demonstrates strong potential in gastrointestinal studies:
• Accelerated healing of ulcers
• Defense against inflammatory bowel disorders
• Restoration of intestinal barrier integrity
• Repair of fistulas (abnormal organ connections)
Evidence highlights faster recovery in:
• Muscle and ligament tears
• Tendon injuries, including difficult Achilles tendon cases
• Bone fractures and delayed unions
• Joint and cartilage damage
Preclinical findings suggest neuroprotective activity:
• Mitigation of traumatic brain injury effects
• Possible benefits in stroke recovery models
• Support for nerve regeneration and repair
• Reduction of neuroinflammatory responses
Research indicates protective roles across multiple organs:
• Liver: Resistance to toxins and alcohol‑related injury
• Heart: Reduced cardiac stress damage and improved recovery
• Kidneys: Protection against drug‑induced nephrotoxicity
• Pancreas: Potential benefits in pancreatitis models
BPC‑157 shows notable vascular activity:
• Rapid angiogenesis (new blood vessel formation)
• Endothelial cell protection
• Enhanced blood flow to injured tissues
• Potential applications in vascular occlusion treatment
BPC‑157 is distinguished by its strong safety profile demonstrated across multiple research models:
Research consistently indicates minimal to no significant adverse reactions.
Even at elevated experimental doses, no toxic outcomes have been documented.
Occasional mild irritation may occur at injection sites.
Demonstrates excellent tolerance across diverse laboratory models.
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Curr Pharm Des, 2018
Stable gastric pentadecapeptide BPC 157 therapy: Responsive disorders and clinical trials. Pharmaceuticals, 2024
BPC 157 enhanced wound healing in alkali burns. Drug Des Devel Ther, 2020
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res, 2019
BPC 157 therapy in inflammatory bowel disease. Biomedicines, 2024
BPC 157 for tissue repair: Mechanism insights and therapeutic potential. Int J Mol Sci, 2023
BPC 157 therapy in neurodegenerative diseases. Front Pharmacol, 2023
Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res, 2022
Zenergen Research Products is committed to supplying high-purity peptides intended for research use, with an emphasis on quality control and dependable delivery.
Copyright© 2026 Zenergen Research - All Rights Reserved.